$WLY

Wiley (WLY) Q1 2027 Earnings Call Transcript

Wiley (WLY) reported Q1 2027 revenue of $386M, down 3% due to a $29M non-recurring AI licensing comparison. Adjusted EBITDA fell 4% to $68M, and adjusted EPS declined 10% to $0.44. Research segment revenue grew 4%, while Learning segment revenue dropped 20%. The company reaffirmed its full-year guidance, targeting low to mid-single-digit organic revenue growth and adjusted EPS of $4.60-$5.05. Management highlighted progress in AI and data analytics initiatives, including partnerships with the U.

Original reporting
Published Sep 9, 2026, 11:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 11:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Wiley (WLY) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$WLYNeutralHigh
01

Why it matters

The earnings release provides fresh financial metrics and guidance, informing valuation models and short‑term trading decisions.

02

Market read

First‑report earnings and FY guidance create actionable insight for traders in the publishing and AI data‑licensing space.

03

What to watch

Emerald acquisition synergies and new AI data‑licensing contracts could boost margins beyond current guidance.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Wiley is a leading scientific publisher transitioning toward AI‑enabled data services.

Company-level read

Ticker impact

$WLYNeutralHigh confidence
Context

Wiley reported Q1 2027 earnings with revenue down 3% and provided FY adjusted EPS guidance of $4.60‑$5.05.

Expected impact

Potential short‑term dip on revenue miss, followed by stabilization if investors focus on higher FY EPS outlook.

Evidence & confidence

The mix of a modest revenue decline and an upgraded EPS outlook creates a balanced catalyst; market reaction will hinge on guidance credibility.

Market effects

Publishing sector may see pressure from AI licensing comparisons, while AI‑related services could gain interest.

U.S. market participants focused on education and scientific publishing stocks.

Limited to investors tracking US‑listed publishing and AI data‑licensing trends.

Counterpoint

The revenue decline may be temporary; AI licensing pipeline could drive stronger growth than guidance suggests.

Key entities

  • John Wiley & Sons, Inc.

    US‑listed scientific publisher (ticker WLY).

  • Matthew S. Kissner

    President and CEO of Wiley, provided guidance.

Related articles

$WLYMed

Wiley’s (WLY) AI Bet Is Starting To Pay Off

John Wiley & Sons (WLY) reported a 3% revenue decline to $386M and a 10% drop in adjusted EPS to $0.44. Research revenue grew 4% to $293M, with AI-related revenue at $14M. The learning segment fell 20% to $93M. Net debt increased to $1.2B, and free cash flow was negative at $70M. The company sees growth in AI and research but faces challenges in learning and debt levels.

$WLYHighAI 8/10

John Wiley & Sons Q1 Earnings Call Highlights

John Wiley & Sons (WLY) reported Q1 earnings with research publishing demand up, submissions rising 31%, and publishing output increasing 8%. The company expects $30M in cost synergies from the Emerald acquisition by year three. AI revenue is on track to exceed $50M in fiscal 2027, with $14M recognized in Q1. Learning revenue declined 20% due to lower print sales and prior-year AI licensing revenue. Guidance was reaffirmed, including organic revenue growth of low-to-mid-single digits and adjuste

$WLYMed

John Wiley & Sons Inc (WLY) (Q1 2027) Earnings Call Highlights: AI Revenue Surges 40%

John Wiley & Sons (WLY) reported Q1 2027 earnings with AI revenue surging 40% to $14M, ahead of full-year target. Research revenue grew 12%, while Learning segment declined 20%. Adjusted EBITDA margin expanded 130 bps to 29.6%. The company raised its dividend for the 33rd consecutive year but faced challenges in professional publishing and higher net interest expense. WLY was selected for key AI partnerships, including with the US Department of Energy and CuspAI, validating its strategic positio

$WLYMedAI 8/10

John Wiley & Sons, Inc. Q1 2027 Earnings Call Summary

John Wiley & Sons reported Q1 2027 earnings, highlighting 31% growth in research submissions and AI revenue exceeding $50M. The Emerald acquisition is performing well, with early cost synergies. Management expects mid-single-digit research growth and long-term margin expansion. GAAP EPS loss of $0.23 was due to restructuring and acquisition costs. Net debt to EBITDA rose to 2.7x post-acquisition. The company raised its dividend for the 33rd consecutive year.

$WLYMed

JOHN WILEY & SONS, INC. (WLY): Results of Operations and Financial Condition

JOHN WILEY & SONS, INC. (WLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Wiley Reports First Quarter 2027 Results; Q1 in line with expectations and full year outlook reaffirmed Strength in Research and AI offset by prior year comparison and softness in Learning – Emerald integration ahead of schedule September 3, 2026 - Hoboken, NJ – Wiley (NYSE: WLY)